Edwards Lifesciences (EW) Other Non-Current Assets (2009 - 2026)

Edwards Lifesciences' Other Non-Current Assets history runs 18 years deep, the most recent figure standing at $738.9 million for Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 0.51% year-over-year to $738.9 million in Q1 2026; TTM through Mar 2026 was $738.9 million, a 0.51% decrease from a year earlier, with the FY2025 full-year figure at $730.2 million, up 6661.11% from the prior year.
• Other Non-Current Assets climbed to $738.9 million in Q1 2026 per EW's latest filing, from $730.2 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $789.8 million in Q2 2024 and bottomed at $10.8 million in Q4 2024.
• The 5-year median for Other Non-Current Assets is $412.1 million (2023), against an average of $422.0 million.
• Across the five-year window, Other Non-Current Assets tumbled 97.67% in 2024 and soared 6661.11% in 2025, its largest moves.
• Year by year, Other Non-Current Assets stood at $299.1 million in 2022, then soared by 54.86% to $463.2 million in 2023, then tumbled by 97.67% to $10.8 million in 2024, then surged by 6661.11% to $730.2 million in 2025, then rose by 1.19% to $738.9 million in 2026.
• Per Business Quant, the three latest EW Other Non-Current Assets figures stand at $738.9 million (Q1 2026), $730.2 million (Q4 2025), and $34.6 million (Q3 2025).